Live Breaking News & Updates on கேட் கருசோ கூர்மையான
Stay updated with breaking news from கேட் கருசோ கூர்மையான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Portage BioTech Inc.: Portage Biotech Added to Russell 2000(R) Index finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Portage BioTech Inc.: Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Portage BioTech Inc.: Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
- Data from the IT-01 trial demonstrate the safety of INT230-6 (PORT-1) as both a monotherapy and in combination with checkpoint inhibitors in solid tumors - Survival data looks favorable compared ....
Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange Common shares will be consolidated on the Nasdaq exchange where shareholders can continue trading under the symbol “PRTG” Portage Biotech Inc., a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that it plans to voluntarily delist its common shares from the Canadian Securities Exchange .Since Portage’s Shares began trading on the … Common shares will be consolidated on the Nasdaq exchange where shareholders can continue trading under the symbol “PRTG” Portage Biotech Inc., (NASDAQ: PRTG) (CSE: PBT.U) (“Portage” or the “Company”) a clinical-stage immuno-oncology company focused on the development of therapies targeting cancer treatment resistance, today announced that it plans to voluntarily delist its common shares (“Shares”) from the Canadian Securities Exchange (the “CSE� ....